The latest gynaecological cancer news
A new study based in Italy found that fasting before and after chemotherapy sessions, when…
A phase 1 study aiming to test tolerability of combination therapy with trastuzumab deruxtecan and…
A phase 3 randomised, double-blind trial published in The Lancet has evaluated the addition of…
Radon is a well-established cause of lung cancer, but its potential role in other malignancies…
The European Commission has approved pembrolizumab plus paclitaxel plus or minus bevacizumab for the treatment…
Endometrial cancer is the most common gynaecologic cancer in the United States and is one…
Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding…
A machine-learning–enabled “electronic nose” capable of identifying ovarian cancer–associated signatures from blood plasma samples has…
New longitudinal data suggest that adding cytology to primary human papillomavirus (HPV) testing provides limited…
A novel DNA-based therapy combined with gemcitabine chemotherapy has demonstrated encouraging survival outcomes in patients…